Womens Laxtive

FDA Drug Profile — Womens Laxative

Womens Laxtive is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Womens Laxative. Available dosage form: tablet, sugar coated.

Drug details

Generic Name
Womens Laxtive
Brand Names
Womens Laxative
Application Number
M007
Sponsor
Allegiant Health
NDC Codes
1
Dosage Forms
TABLET, SUGAR COATED
Routes
ORAL
Active Ingredients
BISACODYL

Indications and Usage

Use(s) for relief of occasional constipation (irregularity) this product generally produces bowel movement in 6 to 12 hours

Warnings

Warnings Do not use if you are unable to swallow without chewing within 1 hour after taking an antacid or milk Ask a doctor before use if you abdominal pain nausea vomiting noticed a sudden change in bowel habits that persists over a period of 2 weeks When using this product do not chew or crush tablets abdominal discomfort, faintness, and cramps may occur Stop use and ask a doctor before use if you need to use more than 1 week rectal bleeding or failure to have a bowel movement after use of a laxative. These may be signs of a serious condition. If pregnant or breastfeeding, ask a health professional before use. Keep out of reach of children In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.